32 Followers SGX:42C - IX Biopharma IX Biopharma
Sector: Health Care, Industry: Biotechnology
Add to Watchlist
Add Alert 

Yahoo Finance

SGD 0.245    +0.0 (+0%)
Show Technical Chart | 1M    3M    6M    1Y    3Y    5Y         

3 Dec 2020


52 Wk Range: 0.13 - 0.35

Day's Range: 0.245 - 0.25

Last Volume: 835,300

Current Yield: 0%

Projected Yield: 0%

SMA-50: SGD 0.25

SMA-200: SGD 0.24

Beta: 0.53

VaR: 49.11%

Liquidity: 2.09M



Market Cap: NA

P/B: 16.78

ROE: -68.47%

Insider Holdings (%): 50.45%


CEO: Mr. Yip Hang Lee

Headquarters: SG

Employees: 0



iX Biopharma Ltd is a Singapore based specialty pharmaceutical and nutraceutical company focused on the development, manufacture, and commercialisation of therapies for the treatment of acute and breakthrough pain, and other health conditions. Its products under development are Wafermine and BnoX for pain management, Wafesil for erectile dysfunction, WafeRest for improved sleep quality, and others. It's business segments are Specialty Pharmaceutical and Nutraceutical business segment. The firm's business segments operate in Singapore, Australia, and China, of which the majority of the revenue comes from Australia.